The role of receptor structure in determining adenosine receptor activity

被引:170
作者
Olah, ME [1 ]
Stiles, GL [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
关键词
adenosine; adenosine receptors; G-proteins; mutagenesis; desensitization; signal transduction;
D O I
10.1016/S0163-7258(99)00051-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine produces a wide variety of physiological effects through the activation of cell surface adenosine receptors (ARs). ARs are members of the G-protein-coupled receptor family, and currently, four subtypes, the A(1)AR, A(2A)AR, A(2B)AR, and A(3)AR, are recognized. This review focuses on the role of receptor structure in governing various facets of AR activity. Ligand-binding properties of ARs are primarily dictated by amino acids in the transmembrane domains of the receptors, although a role for extracellular domains of certain ARs has been suggested. Studies have identified certain amino acids conserved amongst AR subtypes that are critical for ligand recognition, as well as additional residues that may differentiate between agonist and antagonist ligands. Receptor regions responsible for activation of G(s) have been identified for the A(2A)AR. The location of these intracellular sites is consistent with findings described for other G-protein-coupled receptors. Site-directed mutagenesis has been employed to analyze the structural basis for the differences in the kinetics of the desensitization response displayed by various AR subtypes. For the A(2A)AR and A(3)AR, agonist-stimulated phosphorylation of the AR, presumably via a G-protein receptor kinase, has been shown to occur. For these AR subtypes, intracellular regions or individual amino acids that may be targets for this phosphorylation have been identified. Finally, the role of A(1)AR gene structure in regulating the expression of this AR subtype is reviewed. (C) 2000 Elsevier Science Inc All rights reserved.
引用
收藏
页码:55 / 75
页数:21
相关论文
共 132 条
[31]   MOLECULAR CHARACTERIZATION OF A HUMAN BRAIN ADENOSINE-A2 RECEPTOR [J].
FURLONG, TJ ;
PIERCE, KD ;
SELBIE, LA ;
SHINE, J .
MOLECULAR BRAIN RESEARCH, 1992, 15 (1-2) :62-66
[32]   G protein-coupled receptors - II. Mechanism of agonist activation [J].
Gether, U ;
Kobilka, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :17979-17982
[33]   Antagonists of the receptor-G protein interface block G1-coupled signal transduction [J].
Gilchrist, A ;
Mazzoni, MR ;
Dineen, B ;
Dice, A ;
Linden, J ;
Proctor, WR ;
Lupica, CR ;
Dunwiddie, TV ;
Hamm, HE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14912-14919
[34]   ALTERNATIVE SPLICING DIRECTS THE EXPRESSION OF 2 D2 DOPAMINE RECEPTOR ISOFORMS [J].
GIROS, B ;
SOKOLOFF, P ;
MARTRES, MP ;
RIOU, JF ;
EMORINE, LJ ;
SCHWARTZ, JC .
NATURE, 1989, 342 (6252) :923-926
[35]  
GREEN A, 1987, J BIOL CHEM, V262, P15702
[36]  
GREEN A, 1990, J BIOL CHEM, V265, P5206
[37]  
Gubitz AK, 1996, J NEUROCHEM, V67, P374
[38]   The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange [J].
Hall, RA ;
Premont, RT ;
Chow, CW ;
Blitzer, JT ;
Pitcher, JA ;
Claing, A ;
Stoffel, RH ;
Barak, LS ;
Shenolikar, S ;
Weinman, EJ ;
Grinstein, S ;
Lefkowitz, RJ .
NATURE, 1998, 392 (6676) :626-630
[39]  
Hettinger BD, 1998, J NEUROCHEM, V71, P221
[40]  
HettingerSmith BD, 1996, J NEUROCHEM, V67, P1921